Dihydroergotamine Mesylate + Zileuton Interaction
Moderateinteraction on record
Description
Moderate CYP3A4 inhibitor; administer with caution due to potential vasospasm risk.
Mechanism
CYP3A4 inhibition
Source: NLP:dihydroergotamine mesylate
Moderate CYP3A4 inhibitor; administer with caution due to potential vasospasm risk.
CYP3A4 inhibition
Source: NLP:dihydroergotamine mesylate